Activation of inducible nitric oxide synthase by Yongdam-Sagan-Tang in mouse peritoneal macrophages

Journal of Ethnopharmacology

Volumn 60, Issue 1, 1998, Pages 61-69

  Lee, E H ^a   Kim, N K ^a   Hwang, C Y ^a   Kim, H M ^a  

^a Wonkwang University   (South Korea)

Author keywords

Mouse peritoneal macrophages; Nitric oxide; Recombinant interferon ; Tumor necrosis factor ; Yongdam Sagan Tang

Indexed keywords

ENZYME INDUCING AGENT; N(G) METHYLARGININE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; RECOMBINANT GAMMA INTERFERON; STAUROSPORINE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; YONGDAM SAGAN TANG;

ANIMAL CELL; ARTICLE; CHINESE MEDICINE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG POTENTIATION; ENZYME ACTIVATION; ENZYME INDUCTION; MALE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE;

ANIMALS; DRUGS, CHINESE HERBAL; ENZYME ACTIVATION; INTERFERON TYPE II; MACROPHAGES, PERITONEAL; MALE; MICE; MICE, INBRED C57BL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PROTEIN KINASE C; RECOMBINANT PROTEINS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031884327     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-8741(97)00132-3     Document Type: Article

References (42)

1. Amaro M.J., Bartolomé J., Pardo M., Cotonat T., López-Farré A., Carreño V. Decreased nitric oxide production in chronic viral hepatitis B and C. Journal of Medical Virology. 51:1997;326-331.
2. Bolanos J.P., Peuchen S., Heales S.J., Land J.M., Clark J.B. Nitric oxide-mediated inhibition of the mitochondrial respiratory chain in cultured astrocytes. Journal of Neurochemistry. 63:1994;910-916.
3. Brune B., Lapetina E.G. Activation of a cytosolic ADP-ribosyltransferase by nitric oxide-generating agents. Journal of Biological Chemistry. 264:1989;8455-8458.
4. Brune B., Lapetina E.G. Properties of a novel nitric oxide-stimulated ADP-ribosyltransferase. Archives of Biochemistry and Biophysics. 279:1990;286-290.
5. Croen K.D. Evidence for antiviral effect of nitric oxide. Inhibition of herpes simplex virus type I replication. Journal of Clinical Investigation. 91:1993;2446-2452.
6. Esumi H., Tannenbaum S.R. U.S.-Japan Cooperative Cancer Research Program: seminar on nitric oxide synthase and carcinogenesis. Cancer Research. 54:1994;297-301.
7. Garthwaite J., Charles S.L., Chess-Williams R. Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature. 336:1988;385-388.
8. Jun C.D., Choi B.M., Ryu H., Um J.Y., Kwak H.J., Lee B.S., Paik S.G., Kim H.M., Chung H.T. Synergistic cooperation between phorbol ester and IFN-γ for induction of nitric oxide synthesis in murine peritoneal macrophages. Journal of Immunology. 153:1994;3684-3690.
9. Karupiah G., Xie Q.W., Buller R.M., Nathan C., Duarte C., Mac-Micking J.D. Inhibition of viral replication by interferon-gamma-induced nitric oxide synthase. Science. 261:1993;1445-1448.
10. Kilbourn R.G., Klostergaard J., Lopez-Berestein G. Activated macrophages secrete a soluble factor that inhibits mitochondrial respiration of tumor cells. Journal of Immunology. 133:1984;2577-2581.
11. Kim H.M., Moon Y.H. Human chorionic gonadotropin induces nitric oxide synthase mRNA in mouse peritoneal macrophages. Biochemical and Biophysical Research Communications. 229:1996;548-552.
12. Kim, S.O., 1991. Oriental Drug Treatment of Dermatology. Il-Jung-Sa, Seoul, pp. 67.
13. Kots A.Y., Skurat A.V., Sergienko E.A., Bulargina T.V., Severin E.S. Nitroprusside stimulates the cysteine-specific mono (ADP-ribosylation) of glyceraldehyde-3-phosphate dehydrogenase from human erythrocytes. FEBS Letters. 300:1992;9-12.
14. Kwon N.S., Stuehr D.J., Nathan C.F. Inhibition of tumor cell ribonucleotide reductase by macrophage derived nitric oxide. Journal of Experimental Medicine. 174:1991;761-767.
15. Langerman J.A.M., Marielle E.B., Hulst V.D., Nibbering P.H., Furth R.V. Activation of mouse peritoneal macrophages during infection with salmonella thphimurium does not result in enhanced intracellular killing. Journal of Immunology. 144:1990;4340-4346.
16. Lee, S.I., Kang, S.S., 1979. Prescription of Oriental Medicine. Kyechuk-Munwhat-Sa, Seoul, pp. 199.
17. Lepoivre M., Fieschi F., Coves J., Thelander L., Fontecave M. Inactivation of ribonucleotide reductase by nitric oxide. Biochemical and Biophysical Research Communications. 179:1991;442-448.
18. Lowenstein C.J., Alley E.W., Raval P., Snowman A.M., Snyder S.H., Russell S.W., Murphy W.J. Macrophage nitric oxide synthase gene: two upstream regions mediate induction by interferon gamma and lipopolysaccharide. Proceedings of the National Academy of Sciences of USA. 90:1993;9730-9734.
19. Lowenstein C.J., Hill S.L., Lafond-Walker A., Wu J., Allen G., Landavere M., Rose N.R., Herskowitz A. Nitric oxide inhibits viral replication in murine myocarditis. Journal of Clinical Investigation. 97:1996;1837-1843.
20. Mateo R.B., Reichner J.S., Mastrofrancesco B., Kraft-Stolar D., Albina J.E. Impact of nitric oxide on macrophage glucose metabolism and glyceraldehyde-3-phosphate dehydrogenase activity. American Journal of Physiology. 268:1995;C669-C675.
21. Moncada S., Palmer R.M., Higgs E.A. Nitric oxide: Physiology, pathophysiology and pharmacology. Pharmacology Reviews. 43:1991;109-142.
22. Moncada S., Higgs A. The L-arginine-nitric oxide pathway. New England Journal of Medicine. 329:1993;2002-2012.
23. Narumi S., Finke J.H., Hamilton T.A. Interferon gamma and interleukin 2 synergize to induce selective monokine expression in murine peritoneal macrophages. Journal of Biological Chemistry. 265:1990;7036-7041.
24. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB Journal. 6:1992;3051-3064.
25. Nathan C., Xie Q.W. Nitric oxide as a secretory product of mammalian cells. Regulation of biosynthesis of nitric oxide. Journal of Biological Chemistry. 269:1994;13725-13728.
26. Nguyen T., Brunson D., Crespi C.L., Penman B.W., Wishnok J.S., Tannenbaum S.R. DNA damage and mutation in human cells exposed to nitric oxide in vitro. Proceedings of the National Academy of Sciences USA. 89:1992;3030-3034.
27. Nussler A.K., Di Silvio M., Billiar T.R., Hoffman R.A., Geller D.A., Selby R., Madariaga J., Simmons R.L. Stimulation of the nitric oxide synthase pathway in human hepatocytes by cytokines and endotoxin. Journal of Experimental Medicine. 176:1992;261-264.
28. Peng H.B., Libby P., Liao J.K. Induction and stabilization of I kappa B alpha by nitric oxide mediates inhibition of NF-kappa B. Journal of Biological Chemistry. 270:1995;14214-14219.
29. Peunova N., Enikolopov G. Nitric oxide triggers a switch to growth arrest during differentiation of neuronal cells. Nature. 375:1995;68-73.
30. Quiroga J.A., Martín J., Pardo M., Carreño V. Serum levels of soluble immune factors and pathogenesis of chronic hepatitis C and their relation to therapeutic response to interferon alpha. Digestive Diseases and Science. 39:1994;2485-2496.
31. Rice W.G., Schaeffer C.A., Harten B., Villinger F., South T.L., Summers M.F., Henderson L.E., Bess J.W., Arthur L.O. Jr., McDougal J.S. Inhibition of HIV-1 infectivity by zinc-ejecting aromatic C-nitroso compounds. Nature. 361:1993;473-475.
32. Russell S.W., Doe W.F., McIntosh A.T. Functional characterization of a stable noncytolytic stage of macrophage activation in tumors. Journal of Experimental Medicine. 146:1977;1511-1520.
33. Scuderi P., Sterling R.E., Lam K.S., Firiley P.R., Ryan K.J., Ray C.G., Petersen E., Slymen D.J., Salmon S.E. Raised serum levels of tumour necrosis factor in parasitic infections. Lancet. 2:1986;1364-1365.
34. Sheron N., Lau J., Daniels H., Goka J., Eddleston A., Alexander G.J., Williams R. Increased production of tumor necrosis factor alpha in chronic hepatitis B virus infection. Journal of Hepatology. 12:1991;241-245.
35. Summersgill J.T., Powell L.A., Buster B.L., Miller R.D., Ramirez J.A. Killing of Legionella pneumophila by nitric oxide in gamma-interferon activated macrophages. Journal of Leukocyte Biology. 52:1992;625-629.
36. Tucker P.C., Griffin D.E., Choi S., Bui N., Wesselingh S. Inhibition of nitric oxide synthesis increases mortality in Sindbis virus encephalitis. Journal of Virology. 70:1996;3972-3977.
37. Welsh N., Eizirik D.L., Bendtzen K., Sandler S. Interleukin-1 beta-induced nitric oxide production in isolated rat pancreatic islets requires gene transcription and may lead to inhibition of the Krebs cycle enzyme aconitase. Endocrinology. 129:1991;3167-3173.
38. Wink D.A., Kasprzak K.S., Maragos C.M., Elespuru R.K., Misra M., Dunams T.M., Cebula T.A., Koch W.H., Andrews A.W., Allen J.S. et al. DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. Science. 254:1991;1001-1003.
39. Yoshioka K., Kakumu S., Arao M., Tsutsumi Y., Inoue M. Tumor necrosis factor alpha production by peripheral blood mononuclear cells of patients with chronic liver disease. Hepatology. 10:1989;769-773.
40. Xie Q., Whisnant R., Nathan C. Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon-γ and bacterial lipopolysaccharide. Journal of Experimental Medicine. 177:1993;1779-1784.
41. Xie Q.W., Cho H.J., Calaycay J., Mumford R.A., Swiderek K.M., Lee T.D., Ding A., Troso T., Nathan C. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science. 256:1992;225-228.
42. Zhang J., Snyder S.H. Purification of a nitric oxide-stimulated ADP-ribosylated protein using biotinylated beta-nicotinamide adenine dinucleotied. Biochemistry. 32:1993;2228-2233.